Loading...

Anil Tulpule, MD

Title(s)Associate Professor of Clinical Medicine
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
Phone+1 323 865 3927
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Tulpule began his medical education and career in his native India before coming to Southern California on a fellowship in medical oncology at the Keck School of Medicine. After completion of his first USC fellowship, Dr. Tulpule was granted an additional fellowship in the Department of Hematology where he is currently holds an assistant professor appointment. Dr. Tulpule remains active in AIDS research, including a ten year affiliation with the government sponsored AIDS-Related Malignancy Working Group at the National Cancer Institute.

    He has received over fifteen research grants on a number of hematology related subjects and his work has been published in many noted medical journals. Dr. Tulpule is a member of the LAC+USC Medical Center’s Internal Review Board and has a role in determining the ethical implications of the center’s research studies. His dedication to ethical practices also includes a membership of USC Norris Comprehensive Cancer Center’s Patient’s Rights Committee.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry. Acta Haematol. 2020; 143(1):40-50. Lansigan F, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. PMID: 31315113.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study. Cancer. 2019 05 01; 125(9):1507-1517. Park SI, Horwitz SM, Foss FM, Pinter-Brown LC, Carson KR, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Shustov AR. PMID: 30694529.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    3. Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib. J Oncol Pharm Pract. 2019 Apr; 25(3):699-702. Hermel DJ, Chiu V, Hermel MH, Tulpule A, Akhtari M. PMID: 29207935.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2017 Nov 01; 35(31):3538-3546. Leonard JP, Kolibaba KS, Reeves JA, Tulpule A, Flinn IW, Kolevska T, Robles R, Flowers CR, Collins R, DiBella NJ, Papish SW, Venugopal P, Horodner A, Tabatabai A, Hajdenberg J, Park J, Neuwirth R, Mulligan G, Suryanarayan K, Esseltine DL, de Vos S. PMID: 28862883.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    5. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States. Clin Lymphoma Myeloma Leuk. 2017 04; 17(4):193-200. Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, Pro B, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Collie AM, Gruver AM, Grzywacz BJ, Turakhia S, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. PMID: 28209473.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. A prospective cohort study of patients with peripheral T-cell lymphoma in the United States. Cancer. 2017 Apr 01; 123(7):1174-1183. Carson KR, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta MA, Shustov AR, Advani RH, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. PMID: 27911989.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    7. p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study. Am J Clin Pathol. 2014 Apr; 141(4):593-604. Xie Y, Bulbul MA, Ji L, Inouye CM, Groshen SG, Tulpule A, O'Malley DP, Wang E, Siddiqi IN. PMID: 24619762.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    8. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2013 Jan 01; 31(1):58-64. Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A. PMID: 23169503.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    9. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010 Dec; 11(12):1149-59. Wilson WH, O'Connor OA, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP, Tulpule A, Dunleavy K, Xiong H, Chiu YL, Cui Y, Busman T, Elmore SW, Rosenberg SH, Krivoshik AP, Enschede SH, Humerickhouse RA. PMID: 21094089.
      View in: PubMed   Mentions: 225     Fields:    Translation:HumansCellsCTClinical Trials
    10. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010 Aug 15; 116(16):3969-77. Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA. PMID: 20564162.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    11. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood. 2010 Jul 15; 116(2):297-305. Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS. PMID: 20442363.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    12. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010 Jan 28; 115(4):887-95. Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS. PMID: 19965636.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    13. Bendamustine therapy in chronic lymphocytic leukemia. Expert Opin Pharmacother. 2009 Jul; 10(10):1687-98. Masiello D, Tulpule A. PMID: 19527193.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma. J Clin Oncol. 2008 Sep 20; 26(27):4473-9. Robinson KS, Williams ME, van der Jagt RH, Cohen P, Herst JA, Tulpule A, Schwartzberg LS, Lemieux B, Cheson BD. PMID: 18626004.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    15. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. Cancer. 2006 Oct 15; 107(8):1909-17. Straus DJ, Testa MA, Sarokhan BJ, Czuczman MS, Tulpule A, Turner RR, Riggs SA. PMID: 16977654.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    16. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. Clin Lymphoma Myeloma. 2006 Jul; 7(1):59-64. Tulpule A, Espina BM, Berman N, Buchanan LH, Smith DL, Sherrod A, Dharmapala D, Gee C, Boswell WD, Nathwani BN, Welles L, Levine AM. PMID: 16879771.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    17. Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. J Clin Oncol. 2006 Apr 10; 24(11):1712-9. Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS. PMID: 16520466.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    18. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol. 2005 Nov 20; 23(33):8477-82. Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM. PMID: 16230675.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    19. Multidrug resistance in AIDS-related lymphoma. Curr Opin Oncol. 2005 Sep; 17(5):466-8. Tulpule A. PMID: 16093797.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol. 2005 Jul 01; 23(19):4430-8. Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM. PMID: 15883411.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    21. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. J Clin Oncol. 2005 Feb 10; 23(5):990-8. Noy A, Scadden DT, Lee J, Dezube BJ, Aboulafia D, Tulpule A, Walmsley S, Gill P. PMID: 15598977.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    22. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood. 2005 Feb 01; 105(3):1310-8. Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, Gill PS. PMID: 15471957.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    23. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response. J Clin Oncol. 2004 Jul 01; 22(13):2662-70. Levine AM, Tulpule A, Espina B, Sherrod A, Boswell WD, Lieberman RD, Nathwani BN, Welles L. PMID: 15226333.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    24. Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study. Invest New Drugs. 2004 Jan; 22(1):63-8. Tulpule A, Espina BM, Pedro Santabarbara AB, Palmer M, Schiflett J, Boswell W, Smith S, Levine AM. PMID: 14707495.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    25. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer. 2002 Jul 01; 95(1):147-54. Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS. PMID: 12115328.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    26. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer. 2002 Mar 01; 94(5):1500-6. Levine AM, Sadeghi S, Espina B, Tulpule A, Nathwani B. PMID: 11920507.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    27. Multidrug resistance (MDR-1) expression in AIDS-related lymphomas. Leuk Res. 2002 Feb; 26(2):121-7. Tulpule A, Sherrod A, Dharmapala D, Young LL, Espina BM, Sanchez MN, Gill PS, Levine AM. PMID: 11755462.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    28. High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma. . 2001 Dec 15; 28(5):416-21. Bi J, Espina BM, Tulpule A, Boswell W, Levine AM. PMID: 11744828.
      View in: PubMed   Mentions:
    29. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Clin Cancer Res. 2001 Sep; 7(9):2693-702. Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS. PMID: 11555581.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    30. Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer. 2001 Jul; 37(10):1288-95. Levine AM, Tulpule A. PMID: 11423260.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Incidence and management of AIDS-related lymphoma. Oncology (Williston Park). 2001 May; 15(5):629-39; discussion 639-40, 645-6. Levine AM, Seneviratne L, Tulpule A. PMID: 11396357.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma. Ann Oncol. 2001 Apr; 12(4):457-62. Tulpule A, Rarick MU, Kolitz J, Bernstein J, Myers A, Buchanan LA, Espina BM, Traynor A, Letzer J, Justice GR, McDonald D, Roberts L, Boswell W, Nathwani B, Levine AM. PMID: 11398876.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    33. Evolving characteristics of AIDS-related lymphoma. Blood. 2000 Dec 15; 96(13):4084-90. Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS. PMID: 11110677.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    34. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. Blood. 2000 Nov 01; 96(9):3188-94. Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS. PMID: 11050002.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    35. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr. 2000 Aug 15; 24(5):444-50. Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN, Ratner L. PMID: 11035615.
      View in: PubMed   Mentions:
    36. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol. 2000 Feb; 18(4):716-23. Tulpule A, Scadden DT, Espina BM, Cabriales S, Howard W, Shea K, Gill PS. PMID: 10673512.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    37. AIDS-related lymphoma. Blood Rev. 1999 Sep; 13(3):147-50. Tulpule A, Levine A. PMID: 10527266.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    38. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun; 17(6):1876-83. Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. PMID: 10561228.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    39. Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma. Cancer. 1998 Dec 01; 83(11):2370-6. Tulpule A, Schiller G, Harvey-Buchanan LA, Lee M, Espina BM, Khan AU, Boswell W, Nathwani B, Levine AM. PMID: 9840537.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    40. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. J Clin Oncol. 1998 Oct; 16(10):3369-74. Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS. PMID: 9779714.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    41. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1998 Sep; 10(5):413-21. McGarvey ME, Tulpule A, Cai J, Zheng T, Masood R, Espina B, Arora N, Smith DL, Gill PS. PMID: 9800111.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    42. AIDS-Related malignancies. Prim Care. 1998 Jun; 25(2):473-82. Tulpule A, Matheny SC. PMID: 9628964.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst. 1997 Dec 03; 89(23):1797-802. Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. PMID: 9392621.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    44. Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1997 Sep; 9(5):433-9. Jie C, Tulpule A, Zheng T, Masood R, Espina B, Gill PS. PMID: 9327221.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    45. Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. J Clin Oncol. 1997 Mar; 15(3):1094-103. Levine AM, Tulpule A, Tessman D, Kaplan L, Giles F, Luskey BD, Scadden DT, Northfelt DW, Silverberg I, Wernz J, Espina B, Von Hoff D. PMID: 9060550.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    46. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. Ann Oncol. 1997 Jan; 8(1):79-83. Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS. PMID: 9093711.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    47. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med. 1996 Oct 24; 335(17):1261-9. Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC. PMID: 8857005.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    48. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer. 1996 Aug 01; 78(3):517-26. Levine AM, Tulpule A, Espina B, Boswell W, Buckley J, Rasheed S, Stain S, Parker J, Nathwani B, Gill PS. PMID: 8697399.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    49. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995 Apr; 13(4):996-1003. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. PMID: 7707129.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    50. Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study. Cancer Chemother Pharmacol. 1995; 37(1-2):32-8. Israel VK, Jiang C, Muggia FM, Tulpule A, Jeffers S, Leichman L, Morrow CP, Roman L, Leichman CG, Chan KK. PMID: 7497594.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    51. Intraperitoneal 5-fluoro-2'-deoxyuridine with escalating doses of leucovorin: pharmacology and clinical tolerance. Invest New Drugs. 1994; 12(3):197-206. Muggia FM, Tulpule A, Retzios A, Chen F, Jeffers S, Leichman CG, Leichman L, Spears CP, Chan KK. PMID: 7896538.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    52. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia. 1994; 8 Suppl 3:S26-32. Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM. PMID: 7808021.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    Anil's Networks
    Concepts (288)
    Derived automatically from this person's publications.
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _